MUMBAI: Johnson and Johnson said it would work with the Indian government to compensate patients who suffered from artificial hip implants the U.S. healthcare company recalled eight years ago.
Last month, a government panel recommended that J&J pay compensation of at least 2 million rupees ($27,812) to each patient who received an ASR hip implant in India, an estimated 4,700 people. The federal government has asked states to help the patients get relief soon.
“In light of the recent committee report, we are seeking to work with the Indian government to develop an appropriate process for providing further support and compensation for patients in need,” she added.
The ASR hip implants were recalled in 2010 after data suggested they failed at a higher-than-expected rate.
In India, the company paid $2 million to patients for repeat surgeries and about $250,000 in related diagnostic costs under its ASR reimbursement program, but the government panel criticized J&J for offering no compensation.
About 93,000 people worldwide received ASR implants, the panel said in its report to the government, about 4,700 of them in India.
Metal hip implant systems such as ASR were designed to be more durable than a traditional metal-on-plastic, ball-and-socket design. But many Indian patients suffered adverse reactions to the implant, the panel said.
J&J entered the Indian market in 1947 when it started selling its now-ubiquitous baby powder. The company has in recent years faced issues such as price caps on medical devices.
Ruby Khatun joined Medical Dialogue as Reporter in 2016. She covers all the business news in different categories. She also covers all the updates in Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a post graduate from Jamia Hamdard. She can be contacted at firstname.lastname@example.org Contact no. 011-43720751